Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis

被引:0
|
作者
Schmidt, A. [1 ]
Davidson, M. H. [2 ]
Ditmarsch, M. [2 ]
Kastelein, J. J. [2 ]
Finan, C. [1 ]
机构
[1] UCL, London, England
[2] NewAmsterdam Pharm, Naarden, Netherlands
关键词
D O I
10.1093/cvr/cvae088.153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
cvae088.15
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Synthesis of novel β-propanamides to inhibit cholesteryl ester transfer protein (CETP)
    Xie, Hong-Lei
    Liu, Chun-Chi
    Li, Yi-Qun
    Bai, Chang-Lin
    Hao, Chen-Zhou
    Guo, Jing
    Luo, Chang-Qun
    Zhao, Dong-Mei
    Cheng, Mao-Sheng
    CHINESE CHEMICAL LETTERS, 2017, 28 (02) : 260 - 263
  • [32] VARIABILITY GENE EFFECT OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) GENES
    BERG, K
    KONDO, I
    DRAYNA, D
    LAWN, R
    CLINICAL GENETICS, 1989, 35 (06) : 437 - 445
  • [33] The cholesteryl ester transfer protein (CETP) locus and protection against atherosclerosis
    Berg, K
    GENES AND RESISTANCE TO DISEASE, 2000, : 51 - 65
  • [34] Application of Genetic Epidemiology to CETP (Cholesteryl Ester Transfer Protein) Concentration and Risk of Cardiovascular Disease
    Merriman, Tony R.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (05):
  • [35] MECHANISM OF ENHANCEMENT OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITY BY LIPOPROTEIN-LIPASE (LPL)
    TALL, AR
    SAMMETT, D
    CIRCULATION, 1984, 70 (04) : 343 - 343
  • [36] Thyroid hormones increase HDL catabolism and plasma cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice
    Oliveira, HCF
    Berti, JA
    Amaral, MEC
    Boschero, AC
    Harada, LM
    Tall, AR
    ATHEROSCLEROSIS, 1999, 144 : 115 - 115
  • [37] Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
    Mohammadpour, Amir Hooshang
    Akhlaghi, Fatemeh
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 615 - 626
  • [38] BIOCHEMICAL BASIS OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITY DEFICIENCY IN 2 HYPERALPHALIPOPROTEINEMIC SUBJECTS
    MATSUZAWA, Y
    YAMASHITA, S
    SPRECHER, DL
    HARMONY, JAK
    SAKAI, N
    TARUI, S
    WETTERAU, JR
    ARTERIOSCLEROSIS, 1989, 9 (05): : A691 - A691
  • [39] Diphenylpyridylethanamine (DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors
    Harikrishnan, Lalgudi S.
    Finlay, Heather J.
    Qiao, Jennifer X.
    Kamau, Muthoni G.
    Jiang, Ji
    Wang, Tammy C.
    Li, James
    Cooper, Christopher B.
    Poss, Michael A.
    Adam, Leonard P.
    Taylor, David S.
    Chen, Alice Ye A.
    Yin, Xiaohong
    Sleph, Paul G.
    Yang, Richard Z.
    Sitkoff, Doree F.
    Galella, Michael A.
    Nirschl, David S.
    Van Kirk, Katy
    Miller, Arthur V.
    Huang, Christine S.
    Chang, Ming
    Chen, Xue-Qing
    Salvati, Mark E.
    Wexler, Ruth R.
    Lawrence, R. Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6162 - 6175
  • [40] Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
    Amand F. Schmidt
    Nicholas B. Hunt
    Maria Gordillo-Marañón
    Pimphen Charoen
    Fotios Drenos
    Mika Kivimaki
    Deborah A. Lawlor
    Claudia Giambartolomei
    Olia Papacosta
    Nishi Chaturvedi
    Joshua C. Bis
    Christopher J. O’Donnell
    Goya Wannamethee
    Andrew Wong
    Jackie F. Price
    Alun D. Hughes
    Tom R. Gaunt
    Nora Franceschini
    Dennis O. Mook-Kanamori
    Magdalena Zwierzyna
    Reecha Sofat
    Aroon D. Hingorani
    Chris Finan
    Nature Communications, 12